Incidence and Characterization of Neurological Manifestations in Patients with Severe Acute Respiratory Syndrome by COVID-19 in Pernambuco, 2020
DOI:
https://doi.org/10.22478/ufpb.2317-6032.2023v27n3.65062Keywords:
Coronavirus infections, SARS-CoV, Severe Acute Respiratory Syndrome, Neurological manifestations, IncidenceAbstract
Objective: To analyze the incidence and characterization of neurological manifestations in patients with SARS due to COVID-19, in the State of Pernambuco, in 2020. Method: This is a retrospective observational study of cases of neurological manifestations with a history of SARS due to COVID-19, notified to the State Department of Health of Pernambuco, in the year 2020. The database provided includes the variables from the individual record sheet of hospitalized SARS cases. For analysis of categorical variables, Fisher's exact and chi-square tests were used. Results: The incidence of neurological manifestations in patients with SARS due to COVID-19 was 16.36%. Self-reported neurological symptoms from the peripheral nervous system were most common (86.3%), followed by the central nervous system (28.6%) and musculoskeletal system (23.6%). Only 2.5% of patients had clinically verified neurological syndromes/dysfunctions, with Stroke and Alzheimer's disease being the most frequent. Conclusion: The incidence of neurological manifestations in patients with SARS due to COVID-19 is relevant and ranges from mild to life-threatening complications.
Keywords: Coronavirus infections. SARS-CoV. Severe Acute Respiratory Syndrome. Neurological manifestations. Incidence.